EndometriosisConnaiss-EndoNCT06093243
Women's Knowledge About Endometriosis
An observational study of Endometriosis, run by Université de Reims Champagne-Ardenne at 1 site in France.
Trial summary
In the world, 10% of women of childbearing age have endometriosis with diagnostic mostly between 25 and 30 years old. Endometriosis is the leading cause of infertility in our country. A diagnosis delay of approximately 6.7 years is observed for endometriosis. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Endometriosis
- What is being tested?
- data collection
- How many people
- 500 participants
- Where
- 1 siteFrance
- Study dates
- 1 Dec 2023to 1 May 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Study population: women of childbearing age with or without endometriosis
Who may be able to join
- women older than 18
- women of childbearing age
- with or without gynecological history
- agreed to participate in the study
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
About this study
In the world, 10% of women of childbearing age have endometriosis with diagnostic mostly between 25 and 30 years old.
Endometriosis is the leading cause of infertility in our country. A diagnosis delay of approximately 6.7 years is observed for endometriosis.
Read the detailed description
The aim of the study will be to describe knowledge of women about endometriosis.
- Conditions
- Endometriosis
- Being tested
- data collection
- Keywords
- Women, knowledge, endometriosis
- Medical subject headings
- Endometriosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
data collectionOther
data collection
| Study group | Role | What they receive |
|---|---|---|
| "women of childbearing age" group | women of childbearing age with or without endometriosis Receives: Other: data collection |
What is being measured
The primary outcome is the main question the study is designed to answer.
knowledge score on endometriosis symptoms
14 questions with yes/no answers, about symptoms of endometriosis (pain, nausea and vomiting, prolonged heavier period flow,…).
A correct answer earns 1 point and a wrong answer earns 0 points. The knowledge score will therefore be between 0 and 14, the higher the score the better the knowledge.
Measured: Day 0
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2023
- Study start1 Dec 2023 (estimated)
- Primary completion1 Feb 2024 (estimated)
- Study completion1 May 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EndometriosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Université de Reims Champagne-Ardenne
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06093243
- Sponsor's protocol ID
- 2023_RIPH_012_Connaiss-Endo
- Acronym
- Connaiss-Endo
- Status last verified
- Oct 2023
- First submitted
- 9 Oct 2023
- Last updated
- 23 Oct 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 23 Oct 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Women's Knowledge About Endometriosis
- ClinicalTrials.gov ID
- NCT06093243
- Acronym / sponsor ID
- Connaiss-Endo / 2023_RIPH_012_Connaiss-Endo
- Conditions
- Endometriosis
- Keywords
- Women, knowledge, endometriosis
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Université de Reims Champagne-ArdenneUniversity, hospital or other
- Study start
- 1 Dec 2023 (estimated)
- Primary completion
- 1 Feb 2024 (estimated)
- Study completion
- 1 May 2024 (estimated)
- First posted
- 23 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In the world, 10% of women of childbearing age have endometriosis with diagnostic mostly between 25 and 30 years old.
Endometriosis is the leading cause of infertility in our country. A diagnosis delay of approximately 6.7 years is observed for endometriosis.
Detailed description
The aim of the study will be to describe knowledge of women about endometriosis.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| "women of childbearing age" group | – | Other: data collectionwomen of childbearing age with or without endometriosis |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- women of childbearing age with or without endometriosis
Key inclusion criteria (4 listed)
- women older than 18
- women of childbearing age
- with or without gynecological history
- agreed to participate in the study
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| data collectiondata collection | Other | "women of childbearing age" group |
Primary outcome
knowledge score on endometriosis symptoms
Time frame: Day 0
14 questions with yes/no answers, about symptoms of endometriosis (pain, nausea and vomiting, prolonged heavier period flow,…). A correct answer earns 1 point and a wrong answer earns 0 points. The knowledge score will therefore be between 0 and 14, the higher the score the better the knowledge.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Oct 2023.
- Individual participant dataSharing planned: Undecided
Related trials for Endometriosis
Not yet recruiting
Psychotherapy in Patients With Endometriosis: Cognitive Behavioral Therapy Versus Acceptance and Commitment Therapy
Endometriosis, Adenomyosis
Not yet recruitingObservational study
Impact of a Diagnosis or Lack of a Diagnosis of Endometriosis Via a Saliva Test on Pain Catastrophizing, Quality of Life, Symptoms of Anxiety and Depression, and Treatment Adherence
Endometriosis
RecruitingPhase 4
Estetrol/Drospirenone to Reduce the Average Size of Endometriomas
Ovarian Endometrioma, Endometrioma
Recruiting
Evaluating the Feasibility of elleFA App Implementation
Endometriosis
Not yet recruitingPhase 2
PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine Correlates
Endometriosis Pelvic, Endometriosis Ovaries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Endometriosis, run by Université de Reims Champagne-Ardenne at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Barbe Coralie, Dr (0326913665 ext. +33, coralie.barbe1@univ-reims.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
knowledge score on endometriosis symptoms (time frame: Day 0). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2023; AzTrials last refreshed its copy on 5 Nov 2026.